29
Participants
Start Date
August 31, 1997
Primary Completion Date
October 31, 2001
Study Completion Date
October 31, 2001
Recombinant Interleukin-12
Intraperitoneal over 30 minutes once weekly for 4 weeks, repeats every 4 weeks for up to 6 courses
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER